England records 419 GLP-1 drug prescriptions for children in 2025–26


A further 341 prescriptions were issued to under-18s from April to July 2026. The figures cover community dispensing, leaving hospital and private treatment outside the count.
England recorded 419 GLP-1 prescriptions for children under 18 in the 2025–26 financial year, including 10 for children younger than 12. From April to July 2026, there were 341 prescriptions for under-18s, including 15 for the younger age group.
GLP-1 medicines were first developed to help people with type 2 diabetes control their blood sugar and are also used for weight loss. The figures count prescriptions, not individual children, and do not establish how many were for obesity rather than diabetes.
The Guardian obtained the figures from the NHS Business Services Authority through freedom-of-information requests. They cover prescriptions issued in England and dispensed in community settings anywhere in the UK, but exclude private, prison and hospital prescriptions. They therefore do not capture all treatment.
The NHS began piloting Complications from Excess Weight clinics in 2021 for children aged 2 to 16 with severe obesity. In May 2026, NHS England said almost 6,500 children had been referred since the clinics began, including more than 400 younger than 4. Referrals do not mean all those children received medication.
Hundreds of young people have received weight-loss medication through the clinics. Only some clinics can access funding for GLP-1s, which are typically dispensed through hospital pharmacies and therefore fall outside the community figures.
Julian Hamilton-Shield, a professor of diabetes and metabolic endocrinology and a clinician at the Bristol clinic, said children receiving semaglutide there typically have very high excess weight and have not lost weight with dietary and nutritional advice and psychological support. He said most probably also have another condition, such as type 2 diabetes or liver disease. He described the drug as effective and said substantial weight loss could improve children’s sense of control over their lives. He said these children have very low self-esteem, are not attending school and have health complications.
Martin Whyte, a professor of metabolic medicine at the University of Surrey, said children starting the drugs need specialist services and a long-term plan. He recommended regular checks on growth, puberty, nutrition, mental health, eating behaviors and side effects. Weight tends to return when the drugs stop, he said, while data on many years of use in growing young people remain limited.
Dunia Ismail, a consultant pediatrician who runs a clinic, said clinicians use GLP-1s when other options have been exhausted. She warned that without treatment, children could die young or develop heart disease and diabetes. She said her service had been sticking to age 12 and was considering treatment for children aged 8 and above once licensing permits it.
The project plans to distribute 300,000 ceramic filters to households and early childhood centers across Rwanda. Both countries' authorization letters are to follow.
3 min

The insurer is contributing £8.9 million over five years as the Wildfowl & Wetlands Trust plans more than 200 projects to create and restore wetlands across Bristol.
2 min

The Pan American Health Organization reportedly revoked the designation after finding sustained transmission; it did not immediately respond to a request for comment.
2 min